<p>Katherine (Katie) Capps, Co-Founder & Executive Director of the GTMRx Institute as well as Founder & President of Health2 Resources, joined us in this episode of Precision Insights to discuss what comprehensive medication management (CMM) is, and how pharmacogenetics can be used in the CMM process. </p>

Katherine (Katie) Capps, Co-Founder & Executive Director of the GTMRx Institute as well as Founder & President of Health2 Resources, joined us in this episode of Precision Insights to discuss what comprehensive medication management (CMM) is, and how pharmacogenetics can be used in the CMM process.

<p>Katherine (Katie) Capps, Co-Founder &amp; Executive Director of the GTMRx Institute as well as Founder &amp; President of Health2 Resources, joined us in this episode of Precision Insights to discuss what comprehensive medication management (CMM) is, and how pharmacogenetics can be used in the CMM process.&nbsp;</p>

Katie Capps on integrating pharmacogenomic testing into the CMM process

The Precision Insights podcast consists of inspiring conversations around precision medicine with industry thought leaders and innovators. Every two months (and sometimes more), we share the most cutting-edge technologies, processes and initiatives in precision health.

Share Katie Capps on integrating pharmacogenomic testing into the CMM process

Sign up to save your podcasts

Katie Capps on integrating pharmacogenomic testing into the CMM process

Katie Capps on integrating pharmacogenomic testing into the CMM process